Perbio Science's subsidiary Atos Medical AB has acquired the business operations of Therabite Corp

12/19/2002 3:05 AM EST

Perbio Science's subsidiary Atos Medical AB has acquired the business
operations of Therabite Corp.

Perbio Science's subsidiary Atos Medical AB has acquired the business
operations of Therabite Corp., with headquarters in Philadelphia,
Pennsylvania, USA.

This acquisition further strengthens Atos Medical's position within the
ear, nose and throat (ENT) segment, which will give a synergistic effect
within the current organization. It will also contribute positively to
the operating result of the Perbio Group.

Therabite® is a passive training device for patients with trismus,
resulting from surgery and/or radiation treatment that gives rise to a
condition where the muscles used for chewing become damaged for
different reasons. This leads to severely restricted jaw movement
causing problems with speech, nutrition and oral hygiene.

Today, the patient group that is treated with the Provox® Voice
prosthesis and Provox® HME, Atos Medical's main products, often suffers
from trismus.


Further information
Leland G Foster, CEO phone +1 435 757 6432
Claes Wenthzel, Vice President & phone: +46 42 26 90 92
CFO or +46 70 862 01 22


Perbio Science AB (O List, Attract40) is a Swedish biotech company whose
customers are found within research institutions, pharmaceutical
companies and diagnostics manufacturers. The majority of the company's
operations take place in the USA. Perbio Science develops products
within the areas of Bioresearch, Cell Culture and Medical Devices. The
group has 1,241 employees with offices in Sweden, USA and a number of
other countries. The head office is in Helsingborg.

More information regarding Perbio Science can be found at
www.perbio.com.